Filing Details
- Accession Number:
- 0001209191-10-002903
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-01-12 12:00:00
- Reporting Period:
- 2010-01-11
- Filing Date:
- 2010-01-12
- Accepted Time:
- 2010-01-12 18:05:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1333248 | Cadence Pharmaceuticals Inc | CADX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1378847 | A David Socks | C/O Cadence Pharmaceuticals, Inc. 12481 High Bluff Drive San Diego CA 92130 | Svp | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-01-11 | 12,500 | $10.06 | 153,745 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 17, 2009.
Billionaire Hedge Funds
